Empowering Natural Tissue Regeneration.
We are involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
Our proprietary technologies allow for the development of biostructures which are synthetic biologically active tissue engineered products for the restoration of the human skeleton.
Clinical trials for the tissue engineered product, which works by providing a scaffold for the patient’s own bone cells to be regenerated, have been successful.
OUR TECHNOLOGY
Osteopore is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopaedic, and maxillofacial surgery use. Osteopore's proprietary technologies allow for the development of biostructures which are synthetic biologically active tissue engineered products for the restoration of the human skeleton. Osteopore's core technology, the 3D printed biomimetic micro architecture which facilitates the bone healing process, provides multiple opportunities for growth through developing surgical implants and for pursuing regulatory approval for its products to initiate revenue opportunities. 3D printed biomimetic micro architecture is used in all of Osteopore's products.